뒤로
Vicapsys Life Sciences Inc(VICP) 가격
VICP 주가 차트
VICP 주가 예측
Vicapsys Life Sciences Inc
$1.5
0%
$0
종가: Jan 16, 16:00:00 GMT-5
$1.5
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$1.5
시가
$1.5
일일 범위
$1.5 - $1.5
52주 범위
$1 - $3
거래량
225
평균 거래량
310
EPS(TTM)
--
배당수익률
--
시가총액
$48.5M
VICP란 무엇인가요?
Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. The company is headquartered in Cumming, Georgia and currently employs 2 full-time employees. The company went IPO on 2001-07-11. VICAPSYN is the Company’s product line that is applied to transplantation therapies and related stem-cell applications in the transplantation field. The lead product candidate embodiment in transplantation therapy to treat Type 1 Diabetes (T1D) is an encapsulated human islet cell cluster that is intended to restore normal glucose control when implanted into the peritoneal cavity of a patient. The company also develops another product candidate line based on CXCL12 with the trade name of VYBRIN. The clinical applications of VYBRIN are being explored in several areas, including prevention of post-surgical adhesions in abdominal surgery and others.